Medicines shortages in the EU are a “multifaceted challenge” that must be addressed through a “collaborative approach” between the pharmaceutical industry, regulators and policymakers, according to a new position paper from EFPIA, which represents Europe’s R&D pharmaceutical industry.
Key Takeaways
- Industry federation EFPIA has set out recommendations for regulators and policymakers in the EU to tackle medicines supply shortages.
- The federation backs...
In the 19-page document, EFPIA has recommended a series of actions that stakeholders can take to build resilient supply chains and address shortages of medicines in the region. These include...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?